Patent Term Adjustments and Extensions: Recent Developments

Leveraging Exelixis, Other Court Decisions and Recent USPTO Rule Changes to Maximize PTAs and PTEs

Recording of a 90-minute CLE webinar/teleconference with Q&A


Conducted on Tuesday, January 22, 2013
Recorded event now available


This CLE webinar will provide guidance to IP counsel for calculating patent term adjustments and extensions, examine recent court treatment and USPTO rule changes, and offer approaches for maximizing patent term adjustments and extensions.

Description

Patent term adjustment (PTA) practice has seen significant changes beginning with the Federal Circuit’s 2010 decision in Wyeth and Elan Pharma Int’l Ltd. v. Kappos PTA, as well as patent term extension. PTA practice continues to develop with recent rule changes and court decisions.

The USPTO issued its final revision to the PTA rules in Dec. 2011 that allow applicants to promptly file Information Disclosure Statements without incurring a PTA deduction. The USPTO also announced proposed changes to the PTA rules relating to appellate board review.

In two November 2012 decisions, the Eastern District of Virginia and the District of DC concluded the USPTO has been improperly calculating PTA for patents involving a request for continued examination. The rulings could add significant time to the patent term.

Listen as our authoritative panel of patent attorneys examines the recent developments for PTAs, PTEs and their potential impact, methods for calculating PTA and PTE, what can be done to preserve rights, and offers best practices for maximizing PTA and PTE.

Outline

  1. Recent developments
    1. Rule changes
    2. Court treatment
  2. Calculating PTA
    1. 14-4-4-4
    2. Wyeth 3 yr. pendency
    3. RCE and terminal disclaimer impact?
  3. Patent term extensions
    1. Eligibility
    2. Calculation
    3. Restrictions on PTE
  4. Best practices
    1. Preservation of rights
    2. Maximizing PTA vs. PTE

Benefits

The panel will review these and other key questions:

  • How will the recent rule changes by the USPTO change the landscape for PTA and PTE practice?
  • What will be the impact of the recent decisions by the federal district court in Exelixis Inc. v. Kappos and Novartis AG v Kappos?
  • What steps should patent applicants take to maximize PTA and PTE?

Following the speaker presentations, you'll have an opportunity to get answers to your specific questions during the interactive Q&A.

Faculty

Thomas L. Irving, Partner
Finnegan Henderson Farabow Garrett & Dunner, Washington, D.C.

He has 35 years of experience in the field of IP law. His practice includes due diligence, patent prosecution, reissue and reexamination, patent interferences, and counseling, including prelitigation, Orange Book listings of patents covering FDA-approved drugs, and infringement and validity analysis in the chemical fields, as well as litigation. He has served as lead counsel in many patent interferences.

Donna M. Meuth, Senior Patent Counsel, Intellectual Property
Eisai, Andover, Mass.

She has diverse experience in intellectual property law, including patent portfolio management, patent prosecution and litigation. Her technical focus is in the pharmaceutical, chemical and biotechnology arts. She has significant interference experience and litigation experience, in particular ANDA litigation for branded pharmaceuticals.

Margaret J. Sampson, Partner
Vinson & Elkins, Palo Alto, Calif.

Her practice focuses on global strategic patent counseling and patent litigation primarily in the areas of pharmaceuticals, biotechnology, research tools, and medical devices. She has experience advising clients in areas such as Hatch-Waxman patent litigation, drug delivery systems, and genetic engineering. Her scientific experience is in molecular genetics, recombinant DNA, and stem cell research.

Ordering

Online CLE - Audio Recording

Includes streaming audio of full program plus handouts (available 24 hours after live program).

CLE: Pre-approved for participatory or non-traditional/alternate format credit in: CA, HI*, NY*, WV*. Pre-approved for self-study credit in: AK, AZ, MO, MT, TX*, VT, WA.
Upon request, also available in: CO, CT*, FL, GA, ID, KY, LA*, ME, NC, ND, NE, NH, NM, NV, OR*, SC, TN, UT, WI, WY. If you are applying for credit in one of these states, make sure to select those states when placing your order.
(*Indicates that Strafford must report attendance.)

Online CLE Audio $297.00
Available 24 hours after the live event

How does this work?


Recorded Event

Includes full event recording plus handouts (available after live seminar).

CLE: Pre-approved for self-study credit in: AK, AZ, CA, CT, HI, MO, MT, NY, TX*, VT, WA, WV. Upon request, self-study credit is also available in: CO, FL, GA, ID*, KY, ME, ND, NE, NH, NM, NV, OR, UT, WI, WY. If you are applying for self-study credit in one of these states, contact Strafford CLE at 1-800-926-7926 ext. 35 or CLE@straffordpub.com. (*Indicates that Strafford needs to process the CLE — see below to purchase this option.)

Webinar Download (Slide Presentation with Audio) $297.00
Available three business days after the live event

How does this work?

DVD (Slide Presentation with Audio) $297.00 plus $9.45 S&H
Available ten business days after the live event

MP3 Download (Audio with Slide PDFs) $297.00
Available 24 hours after the live event

How does this work?

CD (Audio with Slide PDFs) $297.00 plus $9.45 S&H
Available ten business days after the live event

Webinar/Teleconference

Strafford webinars/teleconferences offer several options for participation: online viewing of speaker-controlled PowerPoint presentations with audio via computer speakers or via phone; or audio only via telephone (download speaker handouts prior to the program).  Please note that our webinars do not feature videos of the presenters.

Program Materials

Requires Adobe Reader 8 or later. Download Acrobat FREE.

Program Materials

Requires Adobe Reader 8 or later. Download Acrobat FREE.

or call 1-800-926-7926

CLE Credit

Strafford's live seminars qualify for CLE in every state that accredits webinars. They offer you a high quality, cost effective, and convenient CLE option, with no lost travel time or expenses.

More Details >

or call 1-800-926-7926

Customer Reviews

The webinar provided insightful analysis of the complicated issues that related to the material.

Gerald Worth

Proskauer Rose

This was the first time our firm participated in a Strafford Webinar and it was very successful.

Cynthia Leonard

Birch, Stewart, Kolasch and Birch

The presentations of the timelines by each speaker were especially valuable! This was an excellent introduction to Strafford's offerings!

Donna Johnson Gressler

Strafford provided an enthusiastic presentation that focused on patent practice, not theory.

David H. Vance

Vance Intellectual Property

I liked the practical insights, particularly when tied to cases the presenters had worked on.

Michael Gray

Kohler

or call 1-800-926-7926

Intellectual Property Law Advisory Board

Stephen R. Baird

Shareholder

Winthrop & Weinstine

Charles S. Baker

Partner

Fulbright & Jaworski

David S. Bloch

Partner

Winston & Strawn

Hung H. Bui

Partner

Bui Garcia-Zamor

Irah H. Donner

Partner

Stroock & Stroock & Lavan

Ian N. Feinberg

Partner

Feinberg Day Alberti & Thompson

Anthony J. Fitzpatrick

Partner

Duane Morris

Bassam N. Ibrahim

Shareholder

Buchanan Ingersoll & Rooney

Craig P. Opperman

Partner

DLA Piper

David Segal

Senior IP Counsel

Intel

Jeffrey R. Seul

Partner

Holland + Knight

Astrid R. Spain

Partner

Jones Day

Mark P. Wine

Partner

Orrick

or call 1-800-926-7926

Our Guarantee

Strafford webinars and teleconferences are backed by our 100% Unconditional Money-Back Guarantee: if you are not satisfied with any of our products, simply let us know and get a full refund. For more information regarding complaints and refunds, please contact us at 1-800-926-7926 ext 10.